Related Experiment Videos
Inversion (X)(p22q13) in a uterine leiomyoma
Y Y Ozisik1, A M Meloni, U Surti
1Cancer Center, Southwest Biomedical Research Institute, Scottsdale, Arizona.
Cancer Genetics and Cytogenetics
|July 15, 1992
Summary
Uterine leiomyoma cases with X chromosome abnormalities, specifically involving Xp22, are presented. These findings suggest that such X chromosome changes can be primary genetic alterations in leiomyoma development.
Area of Science:
- Gynecologic Oncology
- Human Genetics
- Cytogenetics
Background:
- Uterine leiomyomas are common benign tumors of the myometrium.
- Chromosomal abnormalities are frequently observed in leiomyomas, with specific recurrent rearrangements identified.
Observation:
- A case of uterine leiomyoma is presented with a karyotype showing 46,X,inv(X)(p22q13) as the predominant clonal aberration.
- A subpopulation of cells exhibited an additional deletion on chromosome 7 (del(7)), a known primary change in leiomyomas.
Findings:
- The study identifies an inversion on the X chromosome, specifically inv(X)(p22q13), as a significant clonal change in uterine leiomyoma.
- The presence of this X chromosome abnormality, particularly involving the Xp22 region, is proposed as a primary event in leiomyoma pathogenesis.
Implications:
- This research suggests that chromosomal abnormalities of the X chromosome, especially those affecting Xp22, play a crucial role in the development of uterine leiomyomas.
- The findings contribute to understanding the genetic landscape of uterine leiomyomas and may have implications for future diagnostic or therapeutic strategies.